vimarsana.com

Latest Breaking News On - Drug recall - Page 1 : vimarsana.com

Drug recall still voluntary, experts express concern

HP Health minister reveals 1683 drugs failed quality tests in 3 years, prompting experts to call for a more effective drug recall mechanism nationwide. | Latest News India

Himachal pradeshDineshs thakurPrashant reddySubhash mandalIndian pharmaceutical associationCentral drugs standard control organizationRepresentational imageCosmetics rulesTruth pillDrug regulationCosmetics actQuality testsPharmaceutical companiesDrug recall

Sun Pharma recalls 55,000 bottles of generic drug from US market; here s why

The New Jersey-based unit of the Mumbai-based drug major is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

United statesSun pharmaNorthstar rxSun pharmaceutical industries incDrug administrationNew jersey basedFebuxostat tabletsPharmaceutical industriesCurrent good manufacturing practiceDrug recallFebuxostat tabletsGout medicationAnufacturing practice normsEnforcement reportGmp deviationsMicrobial contamination

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene -February 02, 2024 at 09:01 am EST

TARRYTOWN, N.Y., Feb. 02, 2024 Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company , is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal.

United statesInsight pharmaceuticalsDrug administrationPrestige consumer healthcare incPrestige consumer healthcareTolnaftate athleteFoot spray antifungal liquidAntifungal sprayAntifungal spray liquidFoot spray antifungalDrug recallWatch adverse event reporting

Insight Pharmaceuticals Issues Voluntary Nationwide Recall

TARRYTOWN, N.Y., Feb. 02, 2024 (GLOBE NEWSWIRE) Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily.

United statesDrug administrationInsight pharmaceuticalsPrestige consumer healthcare incPrestige consumer healthcareTolnaftate athleteFoot spray antifungal liquidAntifungal sprayAntifungal spray liquidFoot spray antifungalDrug recallWatch adverse event reportingNyse pbhRestige consumer healthcare incInsight pharmaceuticalsPrestige brands

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lot

United statesCompany nameCompany announcementCompany contact informationInsight pharmaceuticalsDrug administrationPrestige consumer healthcare incAnnouncement dateTolnaftate athleteFoot spray antifungalPrestige consumer healthcareFoot spray antifungal liquidAntifungal sprayAntifungal spray liquidDrug recallWatch adverse event reporting

vimarsana © 2020. All Rights Reserved.